🔗 Permalink

Assignee profile:

Oculis Operations Sarl

City:

Lausanne

Country:

Switzerland

Published Applications:

Last publication date:

2026-05-21

Patent Grants:

Last grant date:

2026-01-13

Top Inventors for applications by Oculis Operations Sarl

These are the the leading inventors for applications assigned to Oculis Operations Sarl:

Thorsteinn LOFTSSON 16 Reykjavik, Iceland
Zoltán Fülöp 14 Budapest, Hungary
Zoltán FÜLÖP 7 Budapest, Hungary
Riad Sherif 1 Lausanne, Switzerland

Gudrun Marta Asgrimsdottir 1 Reykjavik, Iceland
Pravin Dugel 1 Phoenix, AZ United States
Sabri Markabi 1 Hallandale Beach, FL United States
Frédéric PILOTAZ 1 Nice, France

Jón Freyr Egilsson 1 Hafnarfjordur, Iceland

Recent patent applications by Oculis Operations Sarl

Oculis Operations Sarl based in Lausanne, CH has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2026-05-21

US20260137805A1

Human necessities

SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY

#2 | 2025-12-25

US20250387411A1

Human necessities

PH STABILIZED OPHTHALMIC COMPOSITIONS

#3 | 2025-10-09

US20250313529A1

Chemistry; metallurgy

SYNTHESIS OF SMALL MOLECULE AGONISTS OF NEUROPTROPHIN

#4 | 2025-06-05 ✅ Patent 12,521,448 granted on 2026-01-13

US20250177561A1

Human necessities

PREPARATION OF SOLID CYCLODEXTRIN COMPLEXES FOR OPHTHALMIC ACTIVE PHARMACEUTICAL INGREDIENT DELIVERY

#5 | 2025-04-17

US20250120985A1

Human necessities

METHOD OF TREATING DIABETIC MACULAR EDEMA

#6 | 2025-01-09 ✅ Patent 12,403,148 granted on 2025-09-02

US20250009762A1

Human necessities

PH STABILIZED OPHTHALMIC COMPOSITIONS

#7 | 2025-01-09 ✅ Patent 12,397,002 granted on 2025-08-26

US20250009761A1

Human necessities

PH STABILIZED OPHTHALMIC DEXAMETHASONE COMPOSITIONS

#8 | 2025-01-09 ✅ Patent 12,383,565 granted on 2025-08-12

US20250009760A1

Human necessities

TREATMENT OF DIABETIC RETINOPATHY WITH OPHTHALMIC COMPOSITIONS

#9 | 2025-01-09 ✅ Patent 12,397,001 granted on 2025-08-26

US20250009759A1

Human necessities

TREATMENT OF OCULAR INFLAMMATION WITH OPHTHALMIC COMPOSITIONS

#10 | 2025-01-09 ✅ Patent 12,397,000 granted on 2025-08-26

US20250009758A1

Human necessities

STABILIZED OPHTHALMIC DEXAMETHASONE COMPOSITIONS

#11 | 2025-01-09 ✅ Patent 12,403,147 granted on 2025-09-02

US20250009757A1

Human necessities

TREATMENT OF OCULAR INFLAMMATION FOLLOWING OCULAR SURGERY

#12 | 2024-11-28

US20240390515A1

Human necessities

MULTIDOSE OPHTHALMIC COMPOSITIONS

#13 | 2024-03-21 ✅ Patent 12,233,133 granted on 2025-02-25

US20240091377A1

Human necessities

Preparation of solid cyclodextrin complexes for ophthalmic active pharmaceutical ingredient delivery

#14 | 2024-02-22 ✅ Patent 12,090,162 granted on 2024-09-17

US20240058362A1

Human necessities

Treatment of diabetic retinopathy

#15 | 2024-02-22

US20240058361A1

Human necessities

OCULAR INFLAMMATION TREATMENT WITH STABILIZED DEXAMETHASONE

#16 | 2024-02-22 ✅ Patent 12,090,161 granted on 2024-09-17

US20240058360A1

Human necessities

Treatment of ocular inflammation

#17 | 2024-02-22 ✅ Patent 12,090,160 granted on 2024-09-17

US20240058359A1

Human necessities

Stabilized dexamethasone compositions

#18 | 2024-02-22

US20240058358A1

Human necessities

PH STABILIZED TOPICAL OPHTHLAMIC COMPOSITIONS

Also check out Oculis Operations Sarl's (Lausanne, Switzerland) applicant profile with 17 patent applications submitted.

AssigneeID:

392394 ⎘